See more : Colliers International Group Inc. (CIGI.TO) Income Statement Analysis – Financial Results
Complete financial analysis of Calumet Specialty Products Partners, L.P. (CLMT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Calumet Specialty Products Partners, L.P., a leading company in the Oil & Gas Exploration & Production industry within the Energy sector.
You may be interested
- NIIT Learning Systems Limited (NIITMTS.NS) Income Statement Analysis – Financial Results
- Nabriva Therapeutics plc (NBRVF) Income Statement Analysis – Financial Results
- RBZ Jewellers Limited (RBZJEWEL.NS) Income Statement Analysis – Financial Results
- PT Cahaya Bintang Medan Tbk (CBMF.JK) Income Statement Analysis – Financial Results
- Innovative Tech Pack Limited (INNOVTEC.BO) Income Statement Analysis – Financial Results
Calumet Specialty Products Partners, L.P. (CLMT)
About Calumet Specialty Products Partners, L.P.
Calumet Specialty Products Partners, L.P. manufactures, formulates, and markets slate of specialty branded products to various consumer-facing and industrial markets in North America and internationally. Its Specialty Products and Solutions segment offers various solvents, waxes, customized lubricating oils, white oils, petrolatums, gels, esters, and other products. The company's Montana/Renewables segment focuses on processing renewable feedstocks into renewable hydrogen, renewable natural gas, renewable propane, renewable naphtha, renewable kerosene/aviation fuel, and renewable diesel. This segment also processes Canadian crude oil into conventional gasoline, diesel, jet fuel, and specialty grades of asphalt. Its Performance Brands segment blends, packages, and markets high performance products through Royal Purple, Bel-Ray, and TruFuel brands. Calumet GP, LLC serves as the general partner for Calumet Specialty Products Partners, L.P. The company was founded in 1916 and is headquartered in Indianapolis, Indiana.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.18B | 4.69B | 3.15B | 2.27B | 3.45B | 3.50B | 3.76B | 3.60B | 4.21B | 5.79B | 5.42B | 4.66B | 3.13B | 2.19B | 1.85B | 2.49B | 1.64B | 1.64B | 1.29B | 539.62M | 430.38M | 316.35M | 306.76M |
| Cost of Revenue | 3.73B | 4.34B | 3.01B | 2.06B | 3.00B | 3.06B | 3.27B | 3.19B | 3.62B | 5.26B | 5.01B | 4.14B | 2.86B | 1.99B | 1.67B | 2.24B | 1.46B | 1.44B | 1.15B | 501.28M | 385.40M | 268.91M | 272.52M |
| Gross Profit | 451.70M | 350.80M | 142.90M | 210.10M | 451.70M | 436.70M | 498.20M | 408.30M | 594.60M | 529.70M | 410.00M | 513.18M | 274.13M | 198.75M | 173.10M | 253.88M | 181.36M | 203.24M | 140.36M | 38.33M | 44.99M | 47.44M | 34.24M |
| Gross Profit Ratio | 10.80% | 7.49% | 4.54% | 9.26% | 13.08% | 12.49% | 13.24% | 11.34% | 14.11% | 9.15% | 7.56% | 11.02% | 8.74% | 9.07% | 9.37% | 10.20% | 11.07% | 12.39% | 10.89% | 7.10% | 10.45% | 15.00% | 11.16% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 133.00M | 141.00M | 151.10M | 202.10M | 259.60M | 259.70M | 275.80M | 279.80M | 311.00M | 269.70M | 224.80M | 168.80M | 50.84M | 35.22M | 32.57M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 54.90M | 53.90M | 52.80M | 47.80M | 53.10M | 58.20M | 65.70M | 110.70M | 146.00M | 149.60M | 62.60M | 41.56M | 94.19M | 85.47M | 67.97M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 187.90M | 194.90M | 203.90M | 249.90M | 312.70M | 317.90M | 341.50M | 390.50M | 457.00M | 419.30M | 287.40M | 210.36M | 145.02M | 120.70M | 100.54M | 120.55M | 77.30M | 78.22M | 69.85M | 47.06M | 9.43M | 9.07M | 7.84M |
| Other Expenses | -3.40M | 21.80M | 20.70M | 26.30M | 17.00M | 10.80M | 3.30M | 1.30M | 1.60M | -2.30M | 2.70M | 470.00K | 3.82M | 6.56M | 5.21M | 125.14M | -81.59M | 81.81M | 72.34M | 50.20M | 47.59M | 38.31M | 43.39M |
| Operating Expenses | 184.50M | 216.70M | 224.60M | 276.20M | 329.70M | 318.60M | 368.90M | 412.30M | 485.80M | 446.90M | 318.40M | 227.25M | 148.84M | 127.26M | 105.74M | 125.14M | -81.59M | 81.81M | 72.34M | 50.20M | 47.59M | 38.31M | 43.39M |
| Cost & Expenses | 3.91B | 4.55B | 3.23B | 2.33B | 3.33B | 3.38B | 3.63B | 3.60B | 4.10B | 5.71B | 5.33B | 4.37B | 3.01B | 2.12B | 1.78B | 2.36B | 1.37B | 1.52B | 1.22B | 551.49M | 432.99M | 307.22M | 315.92M |
| Interest Income | 0.00 | 175.90M | 149.50M | 125.90M | 134.60M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 70.00K | 170.00K | 388.00K | 1.94M | 2.95M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 221.70M | 175.90M | 149.50M | 125.90M | 134.60M | 155.50M | 183.10M | 161.70M | 104.90M | 110.80M | 96.80M | 85.57M | 48.75M | 30.50M | 33.57M | 33.94M | 4.72M | 9.03M | 22.96M | 9.87M | 9.49M | 7.44M | 6.24M |
| Depreciation & Amortization | 146.80M | 121.40M | 124.70M | 120.00M | 128.50M | 130.90M | 179.10M | 185.20M | 145.40M | 138.60M | 117.80M | 91.67M | 74.39M | 64.15M | 72.66M | 61.73M | 17.78M | 11.82M | 10.39M | 6.93M | -7.17M | -3.59M | -2.11M |
| EBITDA | 418.20M | 127.40M | 15.60M | 98.00M | 220.00M | 236.10M | 330.80M | -39.70M | 194.30M | 46.80M | 218.50M | 383.70M | 166.40M | 135.64M | 164.93M | 139.81M | 280.72M | 121.44M | 44.68M | -4.95M | -9.77M | 5.54M | -11.26M |
| EBITDA Ratio | 10.00% | 4.90% | 0.82% | 1.61% | 6.93% | 6.96% | 7.64% | 4.16% | 4.61% | 3.78% | 3.91% | 8.12% | 6.37% | 6.19% | 7.59% | 9.68% | 18.06% | 9.42% | 8.70% | -6.53% | -2.27% | 1.75% | -3.67% |
| Operating Income | 267.20M | 133.40M | -81.90M | -68.60M | 129.20M | 122.90M | 158.00M | -39.70M | 75.00M | 46.80M | 91.60M | 285.93M | 125.29M | 71.49M | 67.36M | 128.74M | 101.20M | 121.44M | 65.69M | -12.19M | -2.60M | 9.13M | -9.16M |
| Operating Income Ratio | 6.39% | 2.85% | -2.60% | -3.02% | 3.74% | 3.51% | 4.20% | -1.10% | 1.78% | 0.81% | 1.69% | 6.14% | 4.00% | 3.26% | 3.65% | 5.17% | 6.18% | 7.40% | 5.10% | -2.26% | -0.61% | 2.89% | -2.98% |
| Total Other Income/Expenses | -217.50M | -301.80M | -176.70M | -76.00M | -119.40M | -173.20M | -189.40M | -256.90M | -242.80M | -159.80M | -87.70M | -79.44M | -81.33M | -54.19M | -5.42M | -84.05M | -17.83M | -27.37M | -54.36M | 12.19M | -2.33M | -3.85M | 2.11M |
| Income Before Tax | 49.70M | -168.40M | -258.60M | -147.90M | -43.10M | -50.30M | -31.40M | -336.30M | -167.80M | -113.00M | 3.90M | 206.49M | 43.97M | 17.30M | 61.94M | 44.69M | 83.38M | 94.07M | 11.33M | 17.68M | -4.93M | 5.28M | -7.05M |
| Income Before Tax Ratio | 1.19% | -3.59% | -8.21% | -6.52% | -1.25% | -1.44% | -0.83% | -9.34% | -3.98% | -1.95% | 0.07% | 4.43% | 1.40% | 0.79% | 3.35% | 1.80% | 5.09% | 5.73% | 0.88% | 3.28% | -1.15% | 1.67% | -2.30% |
| Income Tax Expense | 1.60M | 3.40M | 1.50M | 1.10M | 500.00K | 700.00K | -100.00K | -7.70M | -28.40M | -800.00K | 400.00K | 753.00K | 929.00K | 598.00K | 151.00K | 257.00K | 501.00K | 190.00K | 56.69M | -21.27M | 9.49M | 7.44M | 6.24M |
| Net Income | 48.10M | -171.80M | -260.10M | -149.00M | -43.60M | -55.10M | -103.80M | -328.60M | -139.40M | -112.20M | 3.30M | 204.54M | 86.07M | 16.37M | 60.55M | 44.44M | 82.87M | 93.88M | 11.33M | 8.97M | -4.93M | 5.28M | -13.28M |
| Net Income Ratio | 1.15% | -3.67% | -8.26% | -6.57% | -1.26% | -1.58% | -2.76% | -9.13% | -3.31% | -1.94% | 0.06% | 4.39% | 2.75% | 0.75% | 3.28% | 1.79% | 5.06% | 5.72% | 0.88% | 1.66% | -1.15% | 1.67% | -4.33% |
| EPS | 0.59 | -2.17 | -3.29 | -1.90 | -0.56 | -0.71 | -1.34 | -4.27 | -1.86 | -1.61 | -0.17 | 3.51 | 0.98 | 0.46 | 1.87 | 1.35 | 2.63 | 2.84 | 10.20K | 0.35 | -4.93K | 5.28K | -13.28K |
| EPS Diluted | 0.59 | -2.17 | -3.29 | -1.90 | -0.56 | -0.71 | -1.34 | -4.27 | -1.86 | -1.61 | -0.17 | 3.50 | 0.98 | 0.46 | 1.87 | 1.35 | 2.63 | 2.84 | 10.20K | 0.35 | -4.93K | 5.28K | -13.28K |
| Weighted Avg Shares Out | 80.08M | 79.34M | 78.98M | 78.37M | 78.21M | 77.94M | 77.60M | 77.04M | 74.90M | 69.67M | 67.65M | 55.56M | 42.60M | 35.34M | 32.37M | 32.23M | 16.68M | 14.64M | 1.00K | 25.28M | 1.00K | 1.00K | 1.00K |
| Weighted Avg Shares Out (Dil) | 80.08M | 79.34M | 78.98M | 78.37M | 78.21M | 77.94M | 77.60M | 77.04M | 74.90M | 69.67M | 67.94M | 55.68M | 42.64M | 35.35M | 32.37M | 32.23M | 16.68M | 14.64M | 1.00K | 25.28M | 1.00K | 1.00K | 1.00K |
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Calumet Specialty Products Partners, L.P. - CLMT
NEW YORK , March 4, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Calumet Specialty Products Partners, L.P. ("Calumet" or the "Company") (NASDAQ: CLMT).
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Calumet Specialty Products Partners, L.P. (CLMT)
NEW YORK--(BUSINESS WIRE)---- $CLMT #Investigation--The law firm of Kirby McInerney LLP is investigating potential claims against Calumet Specialty Products Partners, L.P. (“Calumet” or the “Company”) (NASDAQ:CLMT). The investigation concerns whether Calumet and/or certain of its officers have violated the federal...
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Calumet Specialty Products Partners, L.P. (CLMT) on Behalf of Investors
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Calumet Specialty Products Partners, L.P. (“Calumet” or the “Company”) (NASDAQ: CLMT) investors concerning the...
Calumet Recognized by EcoVadis for Commitment to Sustainability
INDIANAPOLIS , Feb. 29, 2024 /PRNewswire/ -- Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) has been recognized by EcoVadis for its Corporate Social Responsibility (CSR) commitment.
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Calumet Specialty Products Partners, L.P.
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Calumet Specialty Products Partners, L.P. (“Calumet” or the “Company”) (NASDAQ: CLMT) investors concerning the Company's possible violations of federal securities laws. On February 23, 2024, Calumet...
The Law Offices of Frank R. Cruz Announces Investigation of Calumet Specialty Products Partners, L.P.
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Calumet Specialty Products Partners, L.P. (“Calumet” or the “Company”) (NASDAQ: CLMT) on behalf of investors concerning the Company's possible violations of federal securities laws. If you are...
Calumet Specialty Products Partners, L.P. (CLMT) Q4 2023 Earnings Call Transcript
Calumet Specialty Products Partners, L.P. (CLMT) Q4 2023 Earnings Call Transcript
Calumet Specialty Products Partners, L.P. Reports Fourth Quarter and Full Year 2023 Results
Full Year 2023 net income of $48.1 million, or Limited partners' interest of $0.59 basic net income per unit Full Year 2023 Adjusted EBITDA of $260.5 million Announced intent to convert corporate structure to a C-Corp from a Master Limited...
Calumet to Release Fourth Quarter and Full Year 2023 Earnings on February 23, 2024
INDIANAPOLIS , Feb. 12, 2024 /PRNewswire/ -- Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) (the "Partnership," "Calumet," "we," "our" or "us"), announced today plans to report results for the fourth quarter and full year 2023 on February 23, 2024.
Calumet Specialty Products Partners, L.P. Announces Execution of Conversion Agreement
INDIANAPOLIS , Feb. 12, 2024 /PRNewswire/ -- Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) ("Calumet," "the Partnership," "we," or "us"), announced today that we have entered into an agreement that sets forth the terms of our previously announced conversion (the...
Source: https://incomestatements.info
Category: Stock Reports